| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,635 |
9,536 |
$594K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,558 |
7,042 |
$560K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,211 |
4,095 |
$276K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,677 |
2,633 |
$247K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
675 |
613 |
$7K |
| 94760 |
|
4,077 |
3,553 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
126 |
111 |
$2K |
| 0013A |
|
15 |
15 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
23 |
21 |
$952.26 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
287 |
257 |
$272.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,441 |
2,354 |
$197.87 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
161 |
149 |
$114.17 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
117 |
115 |
$9.15 |
| 3210F |
|
378 |
329 |
$5.87 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
170 |
155 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
64 |
60 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
125 |
113 |
$0.00 |
| 81005 |
|
18 |
14 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
223 |
206 |
$0.00 |
| 81003 |
|
64 |
58 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
732 |
648 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
240 |
206 |
$0.00 |
| 81002 |
|
17 |
16 |
$0.00 |